Fimepinostat ( CUDC - 907 ) 在复发 / 难治性弥漫性大 B 细胞和高级 B 细胞淋巴瘤患者中 : 2 期试验和探索性生物标志物分析的报告。
关键词: MYC biomarker diffuse large B-cell lymphoma histone deacetylase inhibitor phosphatidylinositol 3-kinase inhibitor
Mesh : Biomarkers, Tumor / analysis Female Histone Deacetylase Inhibitors / administration & dosage therapeutic use Humans Lymphoma, Large B-Cell, Diffuse / drug therapy genetics Lymphoma, Non-Hodgkin / drug therapy genetics Male Middle Aged Morpholines / administration & dosage therapeutic use Phosphoinositide-3 Kinase Inhibitors / administration & dosage therapeutic use Predictive Value of Tests Proto-Oncogene Proteins c-myc / genetics Pyrimidines / administration & dosage therapeutic use Recurrence Safety Treatment Outcome
来 源:
DOI:10.1111/bjh.17730
PDF(Sci-hub)